These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38200929)

  • 1. A 10-Year Retrospective Study on Pediatric Visceral Leishmaniasis in a European Endemic Area: Diagnostic and Short-Course Therapeutic Strategies.
    Dondi A; Manieri E; Gambuti G; Varani S; Campoli C; Zama D; Pierantoni L; Baldazzi M; Prete A; Attard L; Lanari M; Melchionda F
    Healthcare (Basel); 2023 Dec; 12(1):. PubMed ID: 38200929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current clinical, laboratory, and treatment outcome characteristics of visceral leishmaniasis: results from a seven-year retrospective study in Greece.
    Georgiadou SP; Stefos A; Spanakos G; Skrimpas S; Makaritsis K; Sipsas NV; Dalekos GN
    Int J Infect Dis; 2015 May; 34():46-50. PubMed ID: 25743761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Change in human visceral leishmaniasis treatment in Italy: retrospective study of 630 patients].
    Gradoni L; Gramiccia M; Scalone A
    Parassitologia; 2004 Jun; 46(1-2):199-201. PubMed ID: 15305716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double trouble: visceral leishmaniasis in twins after traveling to Tuscany - a case report.
    Adamczick C; Dierig A; Welzel T; Schifferli A; Blum J; Ritz N
    BMC Infect Dis; 2018 Oct; 18(1):495. PubMed ID: 30285634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral Leishmaniasis (VL) Clinical Presentation, Laboratory Findings, Treatment Options and Outcome.
    Khodabandeh M; Moradian E; Sarvari M; Khiabani MS
    Iran J Parasitol; 2024; 19(1):28-37. PubMed ID: 38654944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of
    Alabaz D; Eroğlu F; Elçi H; Çay Ü
    Mediterr J Hematol Infect Dis; 2022; 14(1):e2022053. PubMed ID: 35865400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with miltefosine for persistent or relapsing visceral leishmaniasis in solid organ transplant recipients: A case series from Spain.
    Pérez-Jacoiste Asín MA; Carrasco-Antón N; Fernández-Ruiz M; San Juan R; Alonso-Moralejo R; González E; Andrés A; López-Medrano F; Aguado JM
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27768239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood Visceral Leishmaniasis: Distinctive Features and Diagnosis of a Re-emerging Disease. An 11-year Experience From a Tertiary Referral Center in Athens, Greece.
    Krepis P; Krepi A; Argyri I; Aggelis A; Soldatou A; Papaevangelou V; Tsolia M
    Pediatr Infect Dis J; 2018 May; 37(5):419-423. PubMed ID: 28938257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Visceral childhood leishmaniasis: diagnosis and treatment].
    Prieto Tato LM; La Orden Izquierdo E; Guillén Martín S; Salcedo Lobato E; García Esteban C; García-Bermejo I; Ramos Amador JT
    An Pediatr (Barc); 2010 May; 72(5):347-51. PubMed ID: 20378427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-course Regimens of Liposomal Amphotericin B for the Treatment of Mediterranean Visceral Leishmaniasis in Children: An 11-year Retrospective Study at a Tertiary Care Center.
    Krepis P; Argyri I; Krepi A; Syrmou A; Spyridis N; Tsolia M
    Pediatr Infect Dis J; 2017 Sep; 36(9):849-854. PubMed ID: 28399053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of pediatric visceral leishmaniasis-related hemophagocytic lymphohistiocytosis diagnosed by mNGS.
    Guo F; Kang L; Xu M
    Int J Infect Dis; 2020 Aug; 97():27-29. PubMed ID: 32425641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Four Adult Visceral Leishmaniasis Cases.
    Çabalak M; Çulha G; Kaya T; Gürsoy D; İlhan G; Özbilgin A
    Turkiye Parazitol Derg; 2023 Dec; 47(4):275-279. PubMed ID: 38149450
    [No Abstract]   [Full Text] [Related]  

  • 13. [An adult case of visceral leishmaniasis in a province of Black-Sea region, Turkey].
    Oztoprak N; Aydemir H; Pişkin N; Seremet Keskin A; Araslı M; Gökmen A; Celebi G; Külekçi Uğur A; Taylan Özkan A
    Mikrobiyol Bul; 2010 Oct; 44(4):671-7. PubMed ID: 21063981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Use of Liposomal Amphotericin B in Low Doses in Patients With Visceral Leishmaniasis.
    Ren D; Cao W; Liu X; Han Q; Fan W; Li G; Xia H; Zhang X
    Front Med (Lausanne); 2021; 8():766400. PubMed ID: 34869476
    [No Abstract]   [Full Text] [Related]  

  • 15. Distinct Laboratory and Clinical Features of Secondary Hemophagocytic Lymphohistiocytosis in Pediatric Visceral Leishmaniasis: A Retrospective Analysis of 127 Children in Andalusia, Spain (2004-2019).
    López Marcos M; Ruiz Sáez B; Vílchez Pérez JS; Moreno Pérez D; Carazo Gallego B; Falcón Neyra L; Goycochea Valdivia WA; Obando Santaella I; Lucena Soto JM; Díaz Martos J; Santos Pérez JL; Rodríguez Benjumea M; Angulo González de Lara R; Sánchez Codez MI; Peromingo Matute E; Cruz Cañete M; Calviño Molinero J; Hurtado Mingo Á; Lendínez Molinos F; Medina Claros AF; Muñoz Vilches MJ; Neth O; Olbrich P;
    Pediatr Infect Dis J; 2021 Jun; 40(6):525-530. PubMed ID: 33538542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Microbiological Characteristics of Visceral Leishmaniasis Outbreak in a Northern Italian Nonendemic Area: A Retrospective Observational Study.
    Franceschini E; Puzzolante C; Menozzi M; Rossi L; Bedini A; Orlando G; Gennari W; Meacci M; Rugna G; Carra E; Codeluppi M; Mussini C
    Biomed Res Int; 2016; 2016():6481028. PubMed ID: 27999807
    [No Abstract]   [Full Text] [Related]  

  • 17. Leishmaniasis in Sudan. Visceral leishmaniasis.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 2001 Apr; 95 Suppl 1():S27-58. PubMed ID: 11370250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience.
    Cascio A; di Martino L; Occorsio P; Giacchino R; Catania S; Gigliotti AR; Aiassa C; Iaria C; Giordano S; Colomba C; Polara VF; Titone L; Gradoni L; Gramiccia M; Antinori S
    J Antimicrob Chemother; 2004 Jul; 54(1):217-20. PubMed ID: 15150166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophagocytic Lymphohistiocytosis Associated with Visceral Leishmaniasis: Varied Presentation.
    Ranjan P; Kumar V; Ganguly S; Sukumar M; Sharma S; Singh N; Vikram NK; Pati HP; Sood R
    Indian J Hematol Blood Transfus; 2016 Jun; 32(Suppl 1):351-4. PubMed ID: 27408434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical aspects of visceral leishmaniasis caused by L. infantum in adults. Ten years of experience of the largest outbreak in Europe: what have we learned?
    Horrillo L; Castro A; Matía B; Molina L; García-Martínez J; Jaqueti J; García-Arata I; Carrillo E; Moreno J; Ruiz-Giardin JM; San Martín J
    Parasit Vectors; 2019 Jul; 12(1):359. PubMed ID: 31340851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.